Search
for
Sort by
Research 241–270 of 1000+
- Role of plasminogen activator inhibitor type 1 (PAI-1) in PCOS patient
- A Study on the Clinical and Hormonal Profile of Polycystic Ovarian Syndrome Patients Attending a Tertiary Care Hospital: A Descriptive Cross-sectional Study
- AN OVERVIEW ON POLYCYSTIC OVARIAN SYNDROME
- Prevalence, Symptomatology and Herbal Management of Polycystic Ovarian Syndrome
- Smart Diagnostic System for Health Risk Assessment
- Gene expression of FOXA1 and CCL2 in different phenotypes of infertile women with polycystic ovarian syndrome
- Functional Ingredient Mapping in PCOS Formulations: Hormonal Excess
- Postmenopausal hyperandrogenism of ovarian origin
- DHEA and TNF-α: Key Factors in Managing Polycystic Ovary Syndrome in Iraqi Females
- Estimation of Dehydroepiandrosterone (DHEA) and Tumor Necrosis Factor–Alpha (TNF-α) Levels Women Diagnosed with Polycystic Syndrome
- Review on Diagnostic and Managerial Consequences of PCOS Among Females
- Polycystic Ovary Syndrome: A Comprehensive Review of Its Clinical Presentation, Comorbidities, Long-Term Complications and Management
- A brief report on PCOS: and its inducing model
- Primary High‐Grade Ovarian Sertoli–Leydig Cell Tumor With Bilateral Adnexal Involvement in a Patient Diagnosed With Peutz–Jeghers Syndrome
- Evaluation of Some Hormones Total Antioxidant Capacity and Malondialdehyde Levels in Polycystic Ovarian Syndrome Women attending the gynecology Clinic at Nnewi
- Association of hirsutism and anthropometric profiles with sexual dysfunction and anxiety levels in infertile Indonesian women with polycystic ovarian syndrome
- Predictors of insulin resistance among women with acne vulgaris and polycystic ovarian syndrome presenting to a tertiary care hospital in North India
- MON-913 Testosterone Secreting Ovarian Tumor: A Rare Cause of Erythrocytosis and Pulmonary Embolus
- Metformin potential in predisposing arthralgia, type II cross reactivity secondary to group A streptococcus infection & other comorbidities in treating PCOS
- Androgens and ovarian function: translation from basic discovery research to clinical impact
- Hub biomarkers in ultrasound-guided bladder cancer and osteosarcoma: Myosin light chain kinase and caldesmon
- The role of high serum uric acid levels in androgenic and non-androgenic polycystic ovarian syndrome patients
- A review of hyperandrogenism state in polycystic ovarian syndrome
- METFORMIN EFFECTS ON BLOOD LEVELS OF GREMLIN-1 IN POLYCYSTIC OVARIAN WOMEN.
- 5116 Postmenopausal Hyperandrogenism due to Rare Ovarian Tumor
- 5116 Postmenopausal Hyperandrogenism due to Rare Ovarian Tumor
- 9243 Postmenopausal Hyperandrogenism due to Rare Ovarian Tumor
- METABOLIC, REPRODUCTIVE OUTCOMES AND SIDE EFFECTS AFTER THE ADMINISTRATION OF 100 MG DEHYDROEPIANDROSTERONE (DHEA) IN WOMEN WITH AN ADEQUATE OVARIAN RESERVE
- Is polymorphism of the STK11 gene a predictor of response to metformin in polycystic ovarian syndrome?
- Correlation of skin changes with hormonal changes in polycystic ovarian syndrome: A cross-sectional study clinical study